BioAffinity Technologies Inc - BIAF STOCK NEWS

BIAF : Nasdaq BIAFW : Nasdaq
conferences earnings
BioAffinity Technologies Inc


BIAF Rankings

BIAF Stock Data

Research and Development in Biotechnology
Professional, Scientific, and Technical Services
United States
San Antonio

About BIAF

addressing a critical need to find cancer early and treat cancer specifically bioaffinity technologies, inc. develops tests and therapies to detect and treat cancer at the cellular level. our first product, cypath® flow cytometry for lung cancer (cypath® lung), has been licensed by precision pathology services for continued development and commercial sale as a laboratory developed test. cypath® lung has the potential to dramatically increase overall diagnostic accuracy leading to increased survival, fewer unnecessary invasive procedures and lower patient anxiety and medical costs.